Cadherin 13 (CDH13), a member of the cadherin superfamily, is frequently hypermethylated in various types of cancer including BCP-ALL and was selected to evaluate CpG demethylating effects of HMA [28]. This evidence concerns the gene CDH13 and acute lymphoblastic leukemia.